WO2023214381 - DEVICE AND METHOD FOR THE DETECTION OF BIOMARKERS ASSOCIATED WITH NEURODEGENERATIVE DISEASES

National phase entry:
Publication Number WO/2023/214381
Publication Date 09.11.2023
International Application No. PCT/IB2023/054715
International Filing Date 05.05.2023
Title **
[English] DEVICE AND METHOD FOR THE DETECTION OF BIOMARKERS ASSOCIATED WITH NEURODEGENERATIVE DISEASES
[French] DISPOSITIF ET PROCÉDÉ DE DÉTECTION DE BIOMARQUEURS ASSOCIÉS À DES MALADIES NEURODÉGÉNÉRATIVES
Applicants **
CONSEJO NACIONAL DE INVESTIGACIONES CIENTÍFICAS Y TÉCNICAS (CONICET)
UNIVERSIDAD NACIONAL DE TUCUMÁN
SISTEMA PROVINCIAL DE SALUD DE TUCUMÁN
SKYBIO LLC
UNIVERSIDAD DE BUENOS AIRES
Inventors
VARELA, Oscar José
CHEHÍN, Rosana Nieves
ÁVILA, Cesar Luis
SOCÍAS, Sergio Benjamín
PLOPER, Diego
VERA PINGITORE, Esteban
LUONG, Martín
MANZANO, Verónica Elena
MADRID, Rossana Elena
KOLENDER, Adriana Andrea
MACHÍN, María Belén
PERNICONE, Agustín Osvaldo
SOLIZ SANTANDER, Silvana Estefanía
Priority Data
63/339,220   06.05.2022   US
Application details
Total Number of Claims/PCT *
Number of Independent Claims *
Number of Priorities *
Number of Multi-Dependent Claims *
Number of Drawings *
Pages for Publication *
Number of Pages with Drawings *
Pages of Specification *
*
Number of Office Actions *
*
International Searching Authority
*
Recordal of a Change of the Applicant's Name/Address
*
Type of Assignment
*
Applicant's Legal Status
*
*
*
*
*
*
Entry into National Phase under
*
Patent Delivery
*
Translation

* The data is based on automatic recognition. Please verify and amend if necessary.

** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.

Quotation for National Phase entry

Country StagesTotal
China Filing, Examination, Granting2892
EPO Filing, Examination, Granting21406
Japan Filing, Examination, Granting2923
South Korea Filing, Examination, Granting3642
USA Filing, Examination, Granting9340
MasterCard Visa
Total: 40,203

The term for entry into the National Phase has expired. This quotation is for informational purposes only

Contact Us
Abstract[English] The present disclosure provides devices for the detection and/or quantification of neurotoxic amyloid-type protein aggregates, comprising a doxycycline derivative immobilized on an appropriate surface, as well as electrochemical and immunochemical methods associated to the use of such devices.[French] La présente invention concerne des dispositifs pour la détection et/ou la quantification d'agrégats de protéines de type amyloïde neurotoxiques, comprenant un dérivé de doxycycline immobilisé sur une surface appropriée, ainsi que des procédés électrochimiques et immunochimiques associés à l'utilisation de tels dispositifs.

Rejoining the server...